Gareth Rivalland
- Co-authors
- Thomas JohnPaul MitchellBruce E. LovelandMarzena WalkiewiczFred R. HirschSimon J MitchellHui YuGavin Wright
- Topics
- Lung Cancer Treatments and Mutations (7 papers)Cancer Immunotherapy and Biomarkers (6 papers)Cancer Research and Treatments (5 papers)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Gareth Rivalland
24 papers receiving 247 citations
Peers
Comparison fields: 5 of 54
- Oncology 112
- Pulmonary and Respiratory Medicine 98
- Molecular Biology 78
- Immunology 69
- Epidemiology 30
Countries citing papers authored by Gareth Rivalland
This map shows the geographic impact of Gareth Rivalland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Rivalland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Rivalland more than expected).
Fields of papers citing papers by Gareth Rivalland
This network shows the impact of papers produced by Gareth Rivalland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Rivalland. The network helps show where Gareth Rivalland may publish in the future.
Co-authorship network of co-authors of Gareth Rivalland
This figure shows the co-authorship network connecting the top 25 collaborators of Gareth Rivalland. A scholar is included among the top collaborators of Gareth Rivalland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gareth Rivalland. Gareth Rivalland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 24 | |
| 7 | 16 | |
| 8 | 4 | |
| 9 | 6 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 38 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 5 | |
| 16 | 5 | |
| 17 | 3 | |
| 18 | 36 | |
| 19 | 3 | |
| 20 | 12 |
About Gareth Rivalland
Gareth Rivalland is a scholar working on Biotechnology, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 248 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Oncology (112 citations), Immunology (69 citations) and Pulmonary and Respiratory Medicine (98 citations). Gareth Rivalland has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Thomas John, Paul Mitchell, Bruce E. Loveland, Marzena Walkiewicz, Paul Mitchell, Fred R. Hirsch, Simon J Mitchell, Hui Yu, Gavin Wright and Bibhusal Thapa. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.